Scherr Michaela, Eder Matthias
Department of Hematology, Hemostasis and Oncology, Hannover Medical School, Hannover, Germany.
Cell Cycle. 2007 Feb 15;6(4):444-9. doi: 10.4161/cc.6.4.3807. Epub 2007 Feb 5.
Since some years, activation of RNA interference (RNAi) has been developed into a widely used and powerful biological tool to functionally annotate genomes. Several variants of small regulatory RNAs can trigger this evolutionary highly conserved cellular pathway leading to specific hybridisation to and subsequent degradation or translational repression of target mRNAs. These regulatory RNAs include synthetic double-stranded small interfering RNAs (siRNAs), pol III transcribed small hairpin RNAs (shRNAs), or endogenous or artificial micro RNAs (miRNAs) which are expressed from pol II promoters as primary pri-miRNA transcripts subsequently processed into mature miRNAs in a regulated multi-step process. Depending on the mode of activation RNA-processing and efficacy as well as kinetics of RNAi may differ from transient effects to long-lasting gene silencing. However, one of the major challenges for in vitro and in vivo application of RNAi still remains the efficient delivery of suitable RNAi-triggers to target cells. This review highlights the mechanism of RNAi and its activation, the use of plasmid-based and retro-/ lentiviral vector-based systems to mediate long-term RNAi, kinetic aspects of RNAi and their impact on selection of cell populations with modified gene expression.
近年来,RNA干扰(RNAi)的激活已发展成为一种广泛应用且强大的生物学工具,用于对基因组进行功能注释。几种小调节RNA变体可触发这种在进化上高度保守的细胞途径,导致与靶mRNA特异性杂交并随后降解或抑制其翻译。这些调节RNA包括合成的双链小干扰RNA(siRNA)、由RNA聚合酶III转录的小发夹RNA(shRNA),或内源性或人工微小RNA(miRNA),它们从RNA聚合酶II启动子作为初级pri-miRNA转录本表达,随后在一个受调控的多步骤过程中加工成成熟的miRNA。根据激活方式的不同,RNA加工、RNAi的效率以及动力学可能会有所不同,从瞬时效应到持久的基因沉默。然而,RNAi在体外和体内应用的主要挑战之一仍然是将合适的RNAi触发物有效递送至靶细胞。本综述重点介绍了RNAi及其激活机制、基于质粒和逆转录/慢病毒载体系统介导长期RNAi的应用、RNAi的动力学方面及其对选择具有修饰基因表达的细胞群体的影响。